 Westport, CT, May 28, 2021 GLOBE NEWSWIRE -- BioSig Technologies, Inc. Nasdaq: BSGM BioSig or the Company, a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that Natasha Drapeau, Executive Vice President of BioSig Technologies, Inc. would be presenting at the Jefferies Virtual Healthcare Conference on Thursday, June 3, 2021, at 2 pm ET. 